Abstract
To shed light on the role of bradykinin in preeclampsia in addition to acute hypoxia, we measured the activity of kininase I, the enzyme responsible for its degradation, in umbilical plasma. Kininase I activity in umbilical arteries was compared with that in the umbilical veins. The relationship between kininase I and pH values was also evaluated in women with and without preeclampsia. Also, enzyme activity in supernatants of fetal hepatic cells (NFL/T) cultured under hypoxic or normoxic conditions were determined. Kininase I activity levels in fetal umbilical arteries and veins (n = 33) were similar (r = 0.77). Hypoxia caused suppression of kininase I activity in the supernatant cultures of NFL/T after one hour. However, after 8 and 24 hours, kininase I activity was significantly greater than under normoxic conditions (p < 0.05). Kininase I activity of fetal umbilical vein significantly decreased in the presence of acidemia in the uncomplicated group (n = 75, r = 0.42), whereas the activity negatively correlated with umbilical arterial pH in the preeclamptic group (n = 10, r = - 0.65). Kininase I activity levels in cases complicated with preeclampsia were significantly higher than without preeclampsia (49.2 ± 9.1 vs. 66.2 ± 11.3 nmol/ml/min). The present study indicates that kininase I acts as a regulatory factor in bradykinin degradation.
Key words
Kininase I - Bradykinin - Umbilical blood - Preeclampsia - Fetal hepatic cell
References
-
1
Melmon K L, Cline M J, Hughes C T, Nies A S.
Kinins: possible mediators of neonatal circulatory changes in man.
J Clin Invest.
1968;
47
1295-1302
-
2
Mizutani S, Goto K, Itakura A, Furuhashi M, Kurauchi O, Kikkawa F, Tomoda Y.
Physiological role of placental proteases: interaction between pregnancy-induced bioactive peptides and proteases.
Endcr J.
1995;
41
S93-S104
-
3
Yagami H, Kurauchi O, Murata Y, Okamoto T, Mizutani S, Tomoda Y.
Expression of angiotensin-converting enzyme in human placenta and its physiologic role in the fetal circulation.
Obstet Gynecol.
1994;
84
453-457
-
4
Kuno N, Mizutani S, Ohno Y, Goto K, Itakura A, Kondo I, Kurauchi O, Kikkawa F, Tomoda Y.
Possible involvement of placental proteases in bradykinin (BK) degradation.
Repro Fertil Dev.
1997;
7
633-639
-
5
Ito M, Itakura A, Ohno Y, Nomura M, Senga T, Nagasaka T, Mizutani S.
Possible activation of the renin-angiotensin system in the fetoplacental unit in preeclampsia.
J Clin Endocrinol Metab.
2002;
87
1871-1878
-
6
Kikkawa F, Kajiyama H, Ino K, Watanabe Y, Ito M, Nomura S, Itakura A, Tsujimoto M, Mizutani S.
Possible involvement of placental peptidases that degrade gonadotropin-releasing hormone (GnRH) in the dynamic pattern of placental hCG secretion via GnRH degradation.
Placenta.
2002;
23
483-489
-
7
Ito Y, Mizutani S, Kurauchi O, Kasugai M, Narita O, Tomoda Y.
Purification and properties of microsomal carboxypeptidase N (kininase I) in human placenta.
Enzyme.
1989;
42
8-14
-
8
Mohamed S A, Mizutani S, Salem H T, Mostafa S AM, Itakura A, Hassan N A, Kuno N, Kurauchi O, Tomoda Y.
Changes of placental proteases, which degrade vasoactive peptides, in maternal sera at the onset of preeclampsia.
Med Sci Res.
1995;
23
123-126
-
9
Asada Y, Mizutani S, Kasugai M, Kurauchi O, Tomoda Y.
Relationship between the changes in placental blood flow resistance assessed by Doppler technique and maternal serum placental aminopeptidases, which degrade vaso-active peptides, in pre-eclampsia.
Horm Metab Res.
1992;
24
342-344
-
10
Sardi S P, Perez H, Antunez P, Rothlin R P.
BK B1 receptors in human umbilical vein.
Eur J Pharmacol.
1997;
321
33-38
-
11
Ishida T, Ando H, Nomura S, Ishikawa K, Kurauchi O, Mizutani S, Kobayashi M, Eguchi G, Tomada Y.
Establishment and characterization of human fetal liver epithelial cell line transfected with SV40 T antigen.
Proc Soc Exp Biol Med.
1995;
209
251-256
-
12
Shigematsu S, Ishida S, Gute D C, Korthuis R J.
Postischemic anti-inflammatory effects of bradykinin preconditioning.
Am J Physiol Heart Circ Physiol.
2001;
280
H441-454
-
13
Mizutani S, Ito Y, Nomura S, Kurauchi O, Kasugai M, Narita O, Tomoda Y.
Increased sensitivity to BK in pregnant rats.
Res Commun Chem Pathol Pharmacol.
1989;
64
373-380
-
14
Knock G A, Posteon L.
BK-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia.
Am J Obstet Genecol.
1996;
175
1668-1674
-
15
Maigaard S, Forman A, Andersson K E.
Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit.
Acta Physiol Scand.
1986;
128
23-31
-
16
Gant N F, Whalley P J, Everett R B, Worley R J, MacDonald P C.
Control of vascular reactivity in pregnancy.
Am J Kidney Dis.
1987;
9
303-307
-
17
Nakashima Y, Ohno Y, Itakura A, Takeuchi M, Murata Y, Kuno N, Mizutani S.
Possible involvement of aminopeptidase A in the hypertension with spontaneously hypertensive rat (SHR) and change of refractoriness in response to angiotensin II in pregnant SHR.
J Hypertens.
2002;
20
1-6
-
18
Mizutani S, Yamada R, Kurauchi O, Ito Y, Narita O, Tomoda Y.
Serum aminopeptidase A (APA) in normal pregnancy and pregnancy complicated by pre-eclampsia.
Arch Gynecol.
1987;
240
27-31
A. Itakura, M. D.
Maternity and Perinatal Care Center · Nagoya University Hospital
65 Tsurumai-cho · Showa-ku · Nagoya 466-8550 · Japan
Fax: + 81(52)744-2268
eMail: aita@med.nagoya-u.ac.jp
